1 Familial Hypobetalipoproteinemia

Also Known As:

Hypobetalipoproteinemia, Familial, 1; Acanthocytosis With Hypobetalipoproteinemia; Hypobetalipoproteinemia, Normotriglyceridemic

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Rare Diseases (Rare Disease)

Drugs and Important Biological Agents (IBA) related to 1 Familial Hypobetalipoproteinemia:

1.	Lipoproteins (Lipoprotein)IBA 01/01/2022 - "Type 1 familial hypobetalipoproteinemia (FHBL1), characterized by low levels of apolipoprotein B (ApoB)-containing lipoproteins, elevation of transaminases, and hepatic steatosis, is a rare disease the prevalence of which is 1 in 3,000 among general population. "
2.	Apolipoproteins B (ApoB)IBA 01/01/2022 - "Type 1 familial hypobetalipoproteinemia (FHBL1), characterized by low levels of apolipoprotein B (ApoB)-containing lipoproteins, elevation of transaminases, and hepatic steatosis, is a rare disease the prevalence of which is 1 in 3,000 among general population. "
3.	ApolipoproteinsIBA 01/01/2022 - "Type 1 familial hypobetalipoproteinemia (FHBL1), characterized by low levels of apolipoprotein B (ApoB)-containing lipoproteins, elevation of transaminases, and hepatic steatosis, is a rare disease the prevalence of which is 1 in 3,000 among general population. "
4.	Transaminases (Aminotransferases)IBA 01/01/2022 - "Type 1 familial hypobetalipoproteinemia (FHBL1), characterized by low levels of apolipoprotein B (ApoB)-containing lipoproteins, elevation of transaminases, and hepatic steatosis, is a rare disease the prevalence of which is 1 in 3,000 among general population. "